BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38691588)

  • 1. An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis.
    Paterson RL; La Manna MP; Arena De Souza V; Walker A; Gibbs-Howe D; Kulkarni R; Fergusson JR; Mulakkal NC; Monteiro M; Bunjobpol W; Dembek M; Martin-Urdiroz M; Grant T; Barber C; Garay-Baquero DJ; Tezera LB; Lowne D; Britton-Rivet C; Pengelly R; Chepisiuk N; Singh PK; Woon AP; Powlesland AS; McCully ML; Caccamo N; Salio M; Badami GD; Dorrell L; Knox A; Robinson R; Elkington P; Dieli F; Lepore M; Leonard S; Godinho LF
    Proc Natl Acad Sci U S A; 2024 May; 121(19):e2318003121. PubMed ID: 38691588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
    Joosten SA; van Meijgaarden KE; van Weeren PC; Kazi F; Geluk A; Savage ND; Drijfhout JW; Flower DR; Hanekom WA; Klein MR; Ottenhoff TH
    PLoS Pathog; 2010 Feb; 6(2):e1000782. PubMed ID: 20195504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD8(+) T cells transduced with an additional receptor bispecific for both Mycobacterium tuberculosis and HIV-1 recognize both epitopes.
    Zhou CY; Wen Q; Chen XJ; Wang RN; He WT; Zhang SM; Du XL; Ma L
    J Cell Mol Med; 2016 Oct; 20(10):1984-98. PubMed ID: 27113787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8
    Prezzemolo T; van Meijgaarden KE; Franken KLMC; Caccamo N; Dieli F; Ottenhoff THM; Joosten SA
    Eur J Immunol; 2018 Feb; 48(2):293-305. PubMed ID: 29124751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
    Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
    Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.
    Bian Y; Shang S; Siddiqui S; Zhao J; Joosten SA; Ottenhoff THM; Cantor H; Wang CR
    PLoS Pathog; 2017 May; 13(5):e1006384. PubMed ID: 28475642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.
    van Meijgaarden KE; Haks MC; Caccamo N; Dieli F; Ottenhoff TH; Joosten SA
    PLoS Pathog; 2015 Mar; 11(3):e1004671. PubMed ID: 25803478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.
    Lewinsohn DM; Zhu L; Madison VJ; Dillon DC; Fling SP; Reed SG; Grabstein KH; Alderson MR
    J Immunol; 2001 Jan; 166(1):439-46. PubMed ID: 11123322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules.
    Saraav I; Pandey K; Sharma M; Singh S; Dutta P; Bhardwaj A; Sharma S
    Infect Genet Evol; 2016 Oct; 44():182-189. PubMed ID: 27389362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells.
    McMurtrey C; Harriff MJ; Swarbrick GM; Duncan A; Cansler M; Null M; Bardet W; Jackson KW; Lewinsohn DA; Hildebrand W; Lewinsohn DM
    PLoS One; 2017; 12(11):e0188288. PubMed ID: 29176828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.
    Caccamo N; Pietra G; Sullivan LC; Brooks AG; Prezzemolo T; La Manna MP; Di Liberto D; Joosten SA; van Meijgaarden KE; Di Carlo P; Titone L; Moretta L; Mingari MC; Ottenhoff TH; Dieli F
    Eur J Immunol; 2015 Apr; 45(4):1069-81. PubMed ID: 25631937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8
    Harriff MJ; Wolfe LM; Swarbrick G; Null M; Cansler ME; Canfield ET; Vogt T; Toren KG; Li W; Jackson M; Lewinsohn DA; Dobos KM; Lewinsohn DM
    Sci Rep; 2017 Jul; 7(1):4622. PubMed ID: 28676677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen.
    Jiang ZM; Luo W; Wen Q; Liu SD; Hao PP; Zhou CY; Zhou MQ; Ma L
    J Transl Med; 2015 May; 13():141. PubMed ID: 25943357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis.
    Axelsson-Robertson R; Ju JH; Kim HY; Zumla A; Maeurer M
    Int J Infect Dis; 2015 Mar; 32():13-22. PubMed ID: 25809750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR-like domain antibody against Mycobacterium tuberculosis (Mtb) heat shock protein antigen presented by HLA-A*11 and HLA-A*24.
    Dass SA; Norazmi MN; Acosta A; Sarmiento ME; Tye GJ
    Int J Biol Macromol; 2020 Jul; 155():305-314. PubMed ID: 32240734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis.
    Caccamo N; Meraviglia S; La Mendola C; Bosze S; Hudecz F; Ivanyi J; Dieli F; Salerno A
    Eur J Immunol; 2004 Aug; 34(8):2220-9. PubMed ID: 15259019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of
    Badami GD; La Manna MP; Di Carlo P; Stanek O; Linhartova I; Caccamo N; Sebo P; Dieli F
    Front Immunol; 2023; 14():1289212. PubMed ID: 38106407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach.
    Pandey K; Sharma M; Saarav I; Singh S; Dutta P; Bhardwaj A; Sharma S
    Int J Mycobacteriol; 2016 Mar; 5(1):34-43. PubMed ID: 26927988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in
    Ramaiah A; Nayak S; Rakshit S; Manson AL; Abeel T; Shanmugam S; Sahoo PN; John AJUK; Sundaramurthi JC; Narayanan S; D'Souza G; von Hoegen P; Ottenhoff THM; Swaminathan S; Earl AM; Vyakarnam A
    Front Immunol; 2019; 10():195. PubMed ID: 30814998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
    Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
    Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.